255 related articles for article (PubMed ID: 22197626)
21. High first-trimester maternal blood cystatin C levels despite normal serum creatinine predict pre-eclampsia in singleton pregnancies.
Risch M; Purde MT; Baumann M; Mohaupt M; Mosimann B; Renz H; Raio L; Surbek D; Risch L
Scand J Clin Lab Invest; 2017 Dec; 77(8):634-643. PubMed ID: 29069989
[TBL] [Abstract][Full Text] [Related]
22. New markers in preeclampsia.
Hertig A; Liere P
Clin Chim Acta; 2010 Nov; 411(21-22):1591-5. PubMed ID: 20659441
[TBL] [Abstract][Full Text] [Related]
23. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death.
Spencer K; Cowans NJ; Avgidou K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Oct; 28(5):637-43. PubMed ID: 16952214
[TBL] [Abstract][Full Text] [Related]
24. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy.
Spencer K; Bindra R; Cacho AM; Nicolaides KH
Prenat Diagn; 2004 Mar; 24(3):169-73. PubMed ID: 15057947
[TBL] [Abstract][Full Text] [Related]
25. Placental protein 13 as an early marker for pre-eclampsia: a prospective longitudinal study.
Gonen R; Shahar R; Grimpel YI; Chefetz I; Sammar M; Meiri H; Gibor Y
BJOG; 2008 Nov; 115(12):1465-72. PubMed ID: 19035985
[TBL] [Abstract][Full Text] [Related]
26. Early onset preeclampsia and second trimester serum markers.
Lambert-Messerlian GM; Palomaki GE; Neveux LM; Chien E; Friedman A; Rosene-Montella K; Hayes M; Canick JA
Prenat Diagn; 2009 Dec; 29(12):1109-17. PubMed ID: 19842088
[TBL] [Abstract][Full Text] [Related]
27. Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome.
Huang T; Hoffman B; Meschino W; Kingdom J; Okun N
Prenat Diagn; 2010 May; 30(5):471-7. PubMed ID: 20440736
[TBL] [Abstract][Full Text] [Related]
28. OS090. Performance of candidate clinical and biochemical markers in screening early in pregnancy to detect women at high risk to develop preeclampsia.
Forest JC; Massé J; Bujold E; Rousseau F; Charland M; Thériault S; Lafond J; Giguère Y
Pregnancy Hypertens; 2012 Jul; 2(3):227. PubMed ID: 26105305
[TBL] [Abstract][Full Text] [Related]
29. Prediction of preeclampsia by placental protein 13 and background risk factors and its prevention by aspirin.
Meiri H; Sammar M; Herzog A; Grimpel YI; Fihaman G; Cohen A; Kivity V; Sharabi-Nov A; Gonen R
J Perinat Med; 2014 Sep; 42(5):591-601. PubMed ID: 24607918
[TBL] [Abstract][Full Text] [Related]
30. Performance of a panel of maternal serum markers in predicting preeclampsia at 11-15 weeks' gestation.
Banzola I; Farina A; Concu M; Sekizawa A; Purwosunu Y; Strada I; Arcelli D; Simonazzi G; Caramelli E; Rizzo N
Prenat Diagn; 2007 Nov; 27(11):1005-10. PubMed ID: 17654753
[TBL] [Abstract][Full Text] [Related]
31. Increased fetal DNA in the maternal circulation in early pregnancy is associated with an increased risk of preeclampsia.
Cotter AM; Martin CM; O'leary JJ; Daly SF
Am J Obstet Gynecol; 2004 Aug; 191(2):515-20. PubMed ID: 15343229
[TBL] [Abstract][Full Text] [Related]
32. Longitudinal determination of serum placental protein 13 during development of preeclampsia.
Huppertz B; Sammar M; Chefetz I; Neumaier-Wagner P; Bartz C; Meiri H
Fetal Diagn Ther; 2008; 24(3):230-6. PubMed ID: 18753763
[TBL] [Abstract][Full Text] [Related]
33. Screening for preeclampsia in the first trimester of pregnancy in routine clinical practice in Hungary.
Orosz L; Orosz G; Veress L; Dosa D; Orosz L; Arany I; Fabian A; Medve L; Pap K; Karanyi Z; Toth Z; Poka R; Than NG; Torok O
J Biotechnol; 2019 Jul; 300():11-19. PubMed ID: 31055145
[TBL] [Abstract][Full Text] [Related]
34. Fetal hemoglobin in preeclampsia: a new causative factor, a tool for prediction/diagnosis and a potential target for therapy.
Hansson SR; Gram M; Akerström B
Curr Opin Obstet Gynecol; 2013 Dec; 25(6):448-55. PubMed ID: 24185004
[TBL] [Abstract][Full Text] [Related]
35. First-trimester metabolomic detection of late-onset preeclampsia.
Bahado-Singh RO; Akolekar R; Mandal R; Dong E; Xia J; Kruger M; Wishart DS; Nicolaides K
Am J Obstet Gynecol; 2013 Jan; 208(1):58.e1-7. PubMed ID: 23159745
[TBL] [Abstract][Full Text] [Related]
36. PP054. Predicting preeclampsia at late mid-term pregnancy before occurrence of clinical symptoms: Clinical utility of biomarkers and clinical parameters in a low-risk population.
Forest JC; Massé J; Bujold E; Lafond J; Charland M; Rousseau F; Giguère Y
Pregnancy Hypertens; 2012 Jul; 2(3):271. PubMed ID: 26105377
[TBL] [Abstract][Full Text] [Related]
37. Mean arterial pressure at 11(+0) to 13(+6) weeks in the prediction of preeclampsia.
Poon LC; Kametas NA; Pandeva I; Valencia C; Nicolaides KH
Hypertension; 2008 Apr; 51(4):1027-33. PubMed ID: 18259003
[TBL] [Abstract][Full Text] [Related]
38. Circulating Maternal Total Cell-Free DNA, Cell-Free Fetal DNA and Soluble Endoglin Levels in Preeclampsia: Predictors of Adverse Fetal Outcome? A Cohort Study.
AbdelHalim RM; Ramadan DI; Zeyada R; Nasr AS; Mandour IA
Mol Diagn Ther; 2016 Apr; 20(2):135-49. PubMed ID: 26790664
[TBL] [Abstract][Full Text] [Related]
39. [FIRST-TRIMESTER ULTRASOUND AND BIOCHEMICAL MARKERS AND THEIR PREDICTIVE RATE IN PREECLAMPSIA DEVELOPMENT].
Chalova K; Pehlivanov B
Akush Ginekol (Sofiia); 2015; 54(4):46-51. PubMed ID: 26410947
[TBL] [Abstract][Full Text] [Related]
40. [Targeted screening for pre-eclampsia in the first trimester of pregnancy at Toulouse University Hospital].
Genoux A; Guerby P; Morin M; Perret B; Vayssière C; Hamdi SM
Ann Cardiol Angeiol (Paris); 2018 Jun; 67(3):111-118. PubMed ID: 29786509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
